Evidence map›Paper›PMID 27301076›Full record

ArticleStem cells (Dayton, Ohio)2016

Regulation of WNT Signaling by VSX2 During Optic Vesicle Patterning in Human Induced Pluripotent Stem Cells.

Elizabeth E Capowski, Lynda S Wright, Kun Liang, M Joseph Phillips, Kyle Wallace, Anna Petelinsek, Anna Hagstrom, Isabel Pinilla, Katarzyna Borys, Jessica Lien and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Stem cells (Dayton, Ohio), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. A framework to identify functional interactors that contribute to disrupted early retinal development in Vsx2 ocular retardation J mice.Developmental dynamics : an official publication of the American Association of Anatomists · 2023
    Article
  9. Review
  10. Article
  11. Mutation ofeLife · 2023
    Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Pluripotent Stem Cell-Based Organoid Technologies for Developing Next-Generation Vision Restoration Therapies of Blindness.Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 3 countries.

Elizabeth E CapowskiWaisman Center, University of Wisconsin-Madison, Madison, WI, 53705, USA.
Lynda S WrightWaisman Center, University of Wisconsin-Madison, Madison, WI, 53705, USA.
Kun LiangStatistics and Actuarial Science, University of Waterloo, Waterloo, ON, Canada.
M Joseph PhillipsWaisman Center, University of Wisconsin-Madison, Madison, WI, 53705, USA.
Kyle WallaceWaisman Center, University of Wisconsin-Madison, Madison, WI, 53705, USA.
Anna PetelinsekWaisman Center, University of Wisconsin-Madison, Madison, WI, 53705, USA.
Anna HagstromWaisman Center, University of Wisconsin-Madison, Madison, WI, 53705, USA.
Isabel PinillaAragon Institute for Health Research (IIS Aragón), Lozano Blesa University Hospital, Zaragoza, 50009, Spain.
Katarzyna BorysWaisman Center, University of Wisconsin-Madison, Madison, WI, 53705, USA.
Jessica LienWaisman Center, University of Wisconsin-Madison, Madison, WI, 53705, USA.
Jee Hong MinWaisman Center, University of Wisconsin-Madison, Madison, WI, 53705, USA.
Sunduz KelesDepartment of Statistics, University of Wisconsin-Madison, Madison, WI, 53706, USA.
James A ThomsonMorgridge Institute for Research, Madison, WI, 53715, USA.
David M GammWaisman Center, University of Wisconsin-Madison, Madison, WI, 53705, USA.
University of Wisconsin–Madison · USSmith-Kettlewell Eye Research Institute · USInstituto de Investigación Sanitaria Aragón · ESMorgridge Institute for Research · USUniversity of Waterloo · CA

Funding

WISCONSIN CENTER ON MENTAL RETARDATION: CORE SUPPORTP30HD003352 · NICHD · UNIVERSITY OF WISCONSIN-MADISON · PI SVAREN, JOHN P · 1985 to 2015
$25.2M
Mechanisms of Retinogenesis in Human Stem CellsR01EY021218 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI GAMM, DAVID M · 2010 to 2017
$2.2M
NEI NIH HHS R01 EY021218NICHD NIH HHS P30 HD003352
6 · The paper itself

Abstract

Few gene targets of Visual System Homeobox 2 (VSX2) have been identified despite its broad and critical role in the maintenance of neural retina (NR) fate during early retinogenesis. We performed VSX2 ChIP-seq and ChIP-PCR assays on early stage optic vesicle-like structures (OVs) derived from human iPS cells (hiPSCs), which highlighted WNT pathway genes as direct regulatory targets of VSX2. Examination of early NR patterning in hiPSC-OVs from a patient with a functional null mutation in VSX2 revealed mis-expression and upregulation of WNT pathway components and retinal pigmented epithelium (RPE) markers in comparison to control hiPSC-OVs. Furthermore, pharmacological inhibition of WNT signaling rescued the early mutant phenotype, whereas augmentation of WNT signaling in control hiPSC-OVs phenocopied the mutant. These findings reveal an important role for VSX2 as a regulator of WNT signaling and suggest that VSX2 may act to maintain NR identity at the expense of RPE in part by direct repression of WNT pathway constituents. Stem Cells 2016;34:2625-2634.

Indexed as

Amino Acid SubstitutionBenzothiazolesBiomarkersBody PatterningCell DifferentiationEmbryoid BodiesGene Expression ProfilingGene Expression RegulationHomeodomain ProteinsHumansInduced Pluripotent Stem CellsMicrophthalmia-Associated Transcription FactorMicrophthalmosMutationPhenotypePrimary Cell CultureBenzothiazolesBiomarkersChir 99021Homeodomain ProteinsIWP-2 compoundMicrophthalmia-Associated Transcription FactorMITF protein, humanPyridinesPyrimidinesTranscription FactorsVSX2 protein, humanWnt1 ProteinWNT1 protein, humanHuman induced pluripotent stem cells (hiPSCs)optic vesiclesVSX2WNT

Identifiers

PMID27301076
PMCPMC5156591
OpenAlexW2440415790

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.